Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
< 26 27 26 27 O
1000 27 31 27 31 B-upper_bound
/ 31 32 31 32 I-upper_bound
mL 32 34 32 34 I-upper_bound

Central 0 7 35 42 B-cancer
nervous 8 15 43 50 I-cancer
system 16 22 51 57 I-cancer
metastases 23 33 58 68 I-cancer

Child 0 5 69 74 B-clinical_variable
- 5 6 74 75 I-clinical_variable
Pugh 6 10 75 79 I-clinical_variable
class 11 16 80 85 I-clinical_variable
A 17 18 86 87 I-clinical_variable
with 19 23 88 92 O
no 24 26 93 95 O
clinically 27 37 96 106 O
apparent 38 46 107 115 O
ascites 47 54 116 123 O

Confirmed 0 9 124 133 O
diagnosis 10 19 134 143 O
of 20 22 144 146 O
HCC 23 26 147 150 B-cancer
by 27 29 151 153 O
histological 30 42 154 166 O
examination 43 54 167 178 O

Eastern 0 7 179 186 B-clinical_variable
Cooperative 8 19 187 198 I-clinical_variable
Oncology 20 28 199 207 I-clinical_variable
Group 29 34 208 213 I-clinical_variable
( 35 36 214 215 I-clinical_variable
ECOG 36 40 215 219 I-clinical_variable
) 40 41 219 220 I-clinical_variable
performance 42 53 221 232 I-clinical_variable
status 54 60 233 239 I-clinical_variable
of 61 63 240 242 O
0 64 65 243 244 B-lower_bound
- 65 66 244 245 O
1 66 67 245 246 B-upper_bound

For 0 3 247 250 O
Part 4 8 251 255 O
1 9 10 256 257 O
and 11 14 258 261 O
2 15 16 262 263 O
, 16 17 263 264 O
the 18 21 265 268 O
patient 22 29 269 276 O
has 30 33 277 280 O
unresectable 34 46 281 293 B-chronic_disease
disease 47 54 294 301 I-chronic_disease
and 55 58 302 305 O
has 59 62 306 309 O
been 63 67 310 314 O
previously 68 78 315 325 O
treated 79 86 326 333 O
with 87 91 334 338 O
sorafenib 92 101 339 348 B-treatment

For 0 3 349 352 O
Part 4 8 353 357 O
3 9 10 358 359 O
, 10 11 359 360 O
the 12 15 361 364 O
patient 16 23 365 372 O
has 24 27 373 376 O
not 28 31 377 380 O
received 32 40 381 389 O
prior 41 46 390 395 O
treatment 47 56 396 405 O
with 57 61 406 410 O
a 62 63 411 412 O
TKI 64 67 413 416 B-treatment

Hemoglobin 0 10 417 427 B-clinical_variable
< 11 12 428 429 O
8 12 13 429 430 B-upper_bound
g 14 15 431 432 I-upper_bound
/ 15 16 432 433 I-upper_bound
dL 16 18 433 435 I-upper_bound

International 0 13 436 449 B-clinical_variable
normalized 14 24 450 460 I-clinical_variable
ratio 25 30 461 466 I-clinical_variable
( 31 32 467 468 I-clinical_variable
INR 32 35 468 471 I-clinical_variable
) 35 36 471 472 I-clinical_variable
> 37 38 473 474 O
2.3 38 41 474 477 B-lower_bound

Platelet 0 8 478 486 B-clinical_variable
count 9 14 487 492 I-clinical_variable
< 15 16 493 494 O
75,000 16 22 494 500 B-upper_bound
/ 22 23 500 501 I-upper_bound
mL 23 25 501 503 I-upper_bound

Total 0 5 504 509 O
bilirubin 6 15 510 519 B-clinical_variable
> 16 17 520 521 O
2.5 17 20 521 524 B-lower_bound
mg 21 23 525 527 I-lower_bound
/ 23 24 527 528 I-lower_bound
dL 24 26 528 530 I-lower_bound

alanine 0 7 531 538 B-clinical_variable
aminotransferase 8 24 539 555 I-clinical_variable
( 25 26 556 557 I-clinical_variable
ALT 26 29 557 560 I-clinical_variable
) 29 30 560 561 I-clinical_variable
> 31 32 562 563 O
5x 32 34 563 565 B-lower_bound
the 35 38 566 569 I-lower_bound
upper 39 44 570 575 I-lower_bound
limit 45 50 576 581 I-lower_bound
of 51 53 582 584 I-lower_bound
normal 54 60 585 591 I-lower_bound
( 61 62 592 593 I-lower_bound
ULN 62 65 593 596 I-lower_bound
) 65 66 596 597 I-lower_bound

does 0 4 598 602 O
not 5 8 603 606 O
have 9 13 607 611 O
access 14 20 612 618 O
to 21 23 619 621 O
sorafenib 24 33 622 631 B-treatment

has 0 3 632 635 O
declined 4 12 636 644 O
treatment 13 22 645 654 B-treatment
with 23 27 655 659 I-treatment
sorafenib 28 37 660 669 I-treatment

measured 0 8 670 678 O
creatinine 9 19 679 689 B-clinical_variable
clearance 20 29 690 699 I-clinical_variable
< 30 31 700 701 O
40 31 33 701 703 B-upper_bound
mL 34 36 704 706 I-upper_bound
/ 36 37 706 707 I-upper_bound
min 37 40 707 710 I-upper_bound

prothrombin 0 11 711 722 B-clinical_variable
time 12 16 723 727 I-clinical_variable
( 17 18 728 729 I-clinical_variable
PT 18 20 729 731 I-clinical_variable
) 20 21 731 732 I-clinical_variable
> 22 23 733 734 O
6 23 24 734 735 B-lower_bound
seconds 25 32 736 743 I-lower_bound
above 33 38 744 749 O
control 39 46 750 757 O

spartate 0 8 758 766 B-clinical_variable
aminotransferase 9 25 767 783 I-clinical_variable
( 26 27 784 785 I-clinical_variable
AST 27 30 785 788 I-clinical_variable
) 30 31 788 789 I-clinical_variable

